ENOKIDA TOMOHIRO

エノキダトモヒロ | ENOKIDA TOMOHIRO

Research theme for competitive and other funds (3)：

2022 - 2024 The analysis of microbiome in patients with locally advanced head and neck cancer treated with chemoradiotherapy
2023 - 2024 進行頭頸部がんに対する術後補助療法の標準治療確立のための多施設共同研究
2023 - 頭頸部がんにおける「ふくサポアプリ」を用いた免疫チェックポイント阻害薬による有害事象の評価を目的とした前向き観察研究

Papers (68)：

Yuya Kiguchi, Nagisa Hamamoto, Yukie Kashima, Lucky R. Runtuwene, Aya Ishizaka, Yuta Kuze, Tomohiro Enokida, Nobukazu Tanaka, Makoto Tahara, Shun-Ichiro Kageyama, et al. Giant extrachromosomal element "Inocle" potentially expands the adaptive capacity of the human oral microbiome. 2024
Atsushi Motegi, Shun-ichiro Kageyama, Yukie Kashima, Hidenari Hirata, Hidehiro Hojo, Masaki Nakamura, Takeshi Fujisawa, Tomohiro Enokida, Makoto Tahara, Kazuto Matsuura, et al. Detection of HPV DNA in Saliva of Patients with HPV-Associated Oropharyngeal Cancer Treated with Radiotherapy. Current Oncology. 2024. 31. 8. 4397-4405
Ryutaro Onaga, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida, Hideki Tanaka, Masanobu Sato, Naohiro Takeshita, et al. Clinical impact of a dose-escalation strategy for lenvatinib in differentiated thyroid cancer. International Journal of Clinical Oncology. 2024
Masanobu Sato, Tomohiro Enokida, Takao Fujisawa, Susumu Okano, Naohiro Takeshita, Nobukazu Tanaka, Hideki Tanaka, Atsushi Motegi, Sadamoto Zenda, Takeshi Shinozaki, et al. Induction chemotherapy with paclitaxel, carboplatin, and cetuximab (PCE) followed by chemoradiotherapy for unresectable locoregional recurrence after curative surgery in patients with squamous cell carcinoma of the head and neck. Frontiers in Oncology. 2024. 14
Yuta Hoshi, Tomohiro Enokida, Shingo Tamura, Torahiko Nakashima, Susumu Okano, Takao Fujisawa, Masanobu Sato, Akihisa Wada, Hideki Tanaka, Naohiro Takeshita, et al. Efficacy of anti-PD-1 monotherapy for recurrent or metastatic olfactory neuroblastoma. Frontiers in Oncology. 2024. 14

ｍore...

MISC (191)：

N. Tanaka, T. Enokida, S. Okano, T. Fujisawa, R. Onaga, Y. Hoshi, H. Tanaka, A. Wada, M. Sato, N. Takeshita, et al. 421P Induction chemotherapy and concurrent chemoradiotherapy with cisplatin for T4 nasoethmoidal squamous cell carcinoma: The value of paclitaxel, carboplatin and cetuximab (PCE). Annals of Oncology. 2024. 35. S1561-S1561
久保木諒, 田中伸和, 榎田智弘. 頭頸部領域の希少がんの治療. 腫瘍内科_特集希少がんに対する治療の進歩-婦人科がん,泌尿器がん,肉腫,脳腫瘍,皮膚がんなど-. 2024. 34. 4
Yoshitaka Honma, Ichiro Kinoshita, Masanobu Takahashi, Kazunaga Ishigaki, Tomohiro Enokida, Hideyuki Hayashi, Satoshi Nishiwaki, Naohiro Nishida, Manabu Muto, Kiichiro Ninomiya, et al. Phase II trial of Encorafenib and Binimetinib in patients with BRAF-altered advanced solid tumors: Results of Encorafenib and Binimetinib cohort in the BELIEVE trial. Annals of Oncology (2024) 35 (suppl_2): S482-S535. 10.1016/annonc/annonc1589. 2024
榎田智弘. ウイルス抗原を標的としたがん治療戦略. 第28回日本がん免疫学会総会・第37回日本バイオセラピィ学会学術集会総会合同大会_合同シンポジウム「新規免疫療法のターゲット」. 2024
榎田智弘. 頭頸部癌領域の進歩「甲状腺癌」. WØW!シーズン4 (がん医療研究所主催). 2024

ｍore...

Books (1)：

フローチャートでわかるがん化学療法の副作用 : 地域医療連携サポートBOOK
南山堂 2015 ISBN:9784525785611

Work history (10)：

2021/04 - 現在国立がん研究センター東病院頭頸部内科医員
2015/08 - 現在国立がん研究センター先端開発医療センター免疫TR分野
2019/01 - 2021/03 Division of Hematology Oncology, Laboratory of Nina Bhardwaj, Hess Center for Science & Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mt Sinai, USA Postdoctoral fellow
2017/04 - 2018/12 国立がん研究センター東病院頭頸部内科非常勤医員
2015/04 - 2017/03 国立がん研究センター東病院頭頸部内科がん専門修練医

Show all

Committee career (4)：

2024/11 - 現在 Head and Neck Cancer International Group, Data base committee
2023/07 - 現在 Head and Neck Cancer International Group, Scientific Translational research committee
2022/06 - 現在 JCOG Signatera Pan-Cancer WG
2024/01 - 2024/10 JSCO “Frontier” 2024 review committee

Awards (1)：

2017/03 - 国立がん研究センター国立がん研究センター同窓会賞

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page